What is the treatment for Ureaplasma infections?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 29, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Ureaplasma Infections

Doxycycline 100 mg orally twice daily for 7 days is the first-line treatment for Ureaplasma urealyticum infections. 1, 2, 3

First-Line Treatment Options

  • Doxycycline 100 mg orally twice daily for 7 days is the most effective first-line treatment for Ureaplasma urealyticum infections, as consistently recommended by European Urology guidelines 1, 2
  • This regimen has shown good efficacy in clinical trials and is widely accepted as the standard of care 3, 4

Alternative Treatment Options

  • Azithromycin 1.0-1.5 g orally as a single dose is an effective alternative, particularly when compliance with a 7-day regimen may be an issue 1, 5, 6
  • Erythromycin base 500 mg orally four times a day for 7 days can be used for patients who cannot tolerate doxycycline or azithromycin 7
  • Levofloxacin 500 mg orally once daily for 7 days is another alternative treatment option 2, 3
  • Ofloxacin 300 mg orally twice a day for 7 days can also be considered as an alternative 5, 3

Management of Persistent Infections

  • For persistent or recurrent infection after first-line doxycycline failure, use azithromycin 500 mg orally on day 1, followed by 250 mg daily for 4 days 1, 2
  • After first-line azithromycin failure, consider moxifloxacin 400 mg orally once daily for 7-14 days 1, 3
  • Re-treatment with the initial regimen should be considered if the patient failed to comply with the initial regimen or was re-exposed to an untreated partner 5, 3
  • Objective signs of urethritis should be present before initiating additional antimicrobial therapy 3

Partner Management

  • Sexual partners should be referred for evaluation and treatment while maintaining patient confidentiality 1, 5
  • Treat partners with last sexual contact within 60 days of diagnosis 2, 3
  • Both patients and partners should abstain from sexual intercourse until therapy is completed and symptoms have resolved 5, 3

Special Considerations

  • Single-dose azithromycin may be less effective than multi-day doxycycline for certain Ureaplasma strains, as demonstrated in some studies 8, 4
  • Resistance patterns vary among Ureaplasma species and strains, with increasing reports of resistance to macrolides, tetracyclines, and fluoroquinolones 9, 4
  • For urinary tract infections due to Ureaplasma in patients who cannot tolerate first-line agents, consider fosfomycin 3 g orally as a single dose or nitrofurantoin 100 mg orally every 6 hours 1
  • For pregnant patients with urogenital infections due to Ureaplasma, erythromycin 500 mg orally four times a day for at least 7 days is recommended 7

Follow-Up Recommendations

  • A test of cure is not routinely recommended after completing treatment unless symptoms persist or reinfection is suspected 3
  • If a test of cure is performed, it should be done no earlier than 3 weeks after completion of therapy 3
  • Patients should return for evaluation if symptoms persist or recur after completing therapy 5, 3

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Treatment of Ureaplasma Infections in Men

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Ureaplasma Infection Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Treatment for Mycoplasma genitalium and Ureaplasma Infections

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Ureaplasma: current perspectives.

Indian journal of medical microbiology, 2015

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.